Showing results (191-200 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
American Journal of Respiratory Cell and Molecular Biology|November 25, 2003
Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophilsMary E Bates, Lin Ying Liu, Stephane Esnault, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2022
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma PhenotypeKlaus F Rabe, J Mark FitzGerald, Eric D Bateman, et al.
Brain, Behavior, and Immunity|April 4, 2016
Mind-body interactions in the regulation of airway inflammation in asthma: A PET study of acute and chronic stressMelissa A Rosenkranz, Stephane Esnault, Bradley T Christian, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 26, 2023
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitizationJonathan Corren, Nicola A Hanania, William W Busse, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 7, 2016
Expression of asthma susceptibility genes in bronchial epithelial cells and bronchial alveolar lavage in the Severe Asthma Research Program (SARP) cohortXingnan Li, Gregory A Hawkins, Wendy C Moore, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Quantitative and qualitative analysis of rhinovirus infection in bronchial tissuesAnne G Mosser, Rose Vrtis, Lacinda Burchell, et al.
American Journal of Respiratory and Critical Care Medicine|September 4, 2010
Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research ProgramSilvana Balzar, Merritt L Fajt, Suzy A A Comhair, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2019
An expert consensus framework for asthma remission as a treatment goalAndrew Menzies-Gow, Mona Bafadhel, William W Busse, et al.
The Lancet. Respiratory Medicine|June 28, 2021
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysisWilliam W Busse, Sally E Wenzel, Thomas B Casale, et al.
Pageof 29